| Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases C Galván Casas, A Catala, G Carretero Hernández, ... British Journal of Dermatology 183 (1), 71-77, 2020 | 1756 | 2020 |
| Cutaneous reactions after SARS‐CoV‐2 vaccination: a cross‐sectional Spanish nationwide study of 405 cases* A Català, C Muñoz‐Santos, C Galván‐Casas, M Roncero Riesco, ... British Journal of Dermatology 186 (1), 142-152, 2022 | 252 | 2022 |
| CLOVES syndrome: review of a PIK3CA‐related overgrowth spectrum (PROS) A Martinez‐Lopez, G Blasco‐Morente, I Perez‐Lopez, JD Herrera‐Garcia, ... Clinical genetics 91 (1), 14-21, 2017 | 128 | 2017 |
| Spanish evidence-based guidelines on the treatment of psoriasis with biologic agents, 2013. Part 1: on efficacy and choice of treatment L Puig, JM Carrascosa, G Carretero, P De La Cueva, RF Lafuente-Urrez, ... Actas Dermo-Sifiliográficas (English Edition) 104 (8), 694-709, 2013 | 110 | 2013 |
| Fundamentos de bioquímica estructural JM Teijón Editorial Tébar, 2006 | 100 | 2006 |
| Off‐Label Uses of Anti‐TNF Therapy in Three Frequent Disorders: Behçet’s Disease, Sarcoidosis, and Noninfectious Uveitis D Sánchez-Cano, JL Callejas-Rubio, R Ruiz-Villaverde, ... Mediators of Inflammation 2013 (1), 286857, 2013 | 74 | 2013 |
| Maculopapular eruptions associated to COVID‐19: a subanalysis of the COVID‐Piel study A Català, C Galván‐Casas, G Carretero‐Hernández, ... Dermatologic Therapy 33 (6), e14170, 2020 | 70 | 2020 |
| Ultrasound as a diagnostic and management tool in hidradenitis suppurativa patients: a multicentre study A Martorell, F Alfageme Roldán, E Vilarrasa Rull, R Ruiz‐Villaverde, ... Journal of the European Academy of Dermatology and Venereology 33 (11), 2137 …, 2019 | 70 | 2019 |
| Chilblain‐like lesions in pediatrics dermatological outpatients during the COVID‐19 outbreak G Garcia‐Lara, L Linares‐González, T Ródenas‐Herranz, ... Dermatologic therapy 33 (5), e13516, 2020 | 66 | 2020 |
| Redefining the therapeutic objective in psoriatic patients candidates for biological therapy G Carretero, L Puig, JM Carrascosa, L Ferrándiz, R Ruiz-Villaverde, ... Journal of Dermatological Treatment 29 (4), 334-346, 2018 | 56 | 2018 |
| Treatment of moderate‐to‐severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series JC Armario‐Hita, J Pereyra‐Rodriguez, JF Silvestre, R Ruiz‐Villaverde, ... British Journal of Dermatology 181 (5), 1072-1074, 2019 | 50 | 2019 |
| Directrices españolas basadas en la evidencia para el tratamiento de la psoriasis con agentes biológicos, 2013. I. Consideraciones de eficacia y selección del tratamiento L Puig, JM Carrascosa, G Carretero, P De la Cueva, RF Lafuente-Urrez, ... Actas Dermo-Sifiliográficas 104 (8), 694-709, 2013 | 49 | 2013 |
| Bullous pemphigoid and COVID-19 vaccine I Pérez-López, D Moyano-Bueno, R Ruiz-Villaverde Medicina Clinica (English Ed.) 157 (10), e333, 2021 | 44 | 2021 |
| Successful treatment of type 1 pityriasis rubra pilaris with ustekinumab therapy RR Villaverde, DS Cano European Journal of Dermatology 20 (5), 630-631, 2010 | 43 | 2010 |
| Sexual distress in patients with hidradenitis suppurativa: a cross-sectional study C Cuenca-Barrales, R Ruiz-Villaverde, A Molina-Leyva Journal of clinical medicine 8 (4), 532, 2019 | 37 | 2019 |
| Pilot study of sexual dysfunction in patients with psoriasis: influence of biologic therapy R Ruiz-Villaverde, D Sánchez-Cano, JR Rodrigo, CV Gutierrez Indian Journal of Dermatology 56 (6), 694-699, 2011 | 37 | 2011 |
| Generalized annular granuloma: response to isotretinoin. A Buendía-Eisman, R Ruiz-Villaverde, J Blasco-Melguizo, ... International journal of dermatology 42 (4), 2003 | 37 | 2003 |
| Pitted keratolysis: an infective cause of foot odour P Fernández-Crehuet, R Ruiz-Villaverde CMAJ 187 (7), 519-519, 2015 | 36 | 2015 |
| Therapeutic approach to skin reactions caused by personal protective equipment (PPE) during COVID‐19 pandemic: An experience from a tertiary hospital in Granada, Spain FJ Navarro‐Triviño, R Ruiz‐Villaverde Dermatologic therapy 33 (6), 2020 | 34 | 2020 |
| Fifty‐two week follow‐up safety and effectiveness results of dupilumab treatment of moderate‐to‐severe atopic dermatitis from a retrospective, multicentric series R Ruiz‐Villaverde, J Dominguez‐Cruz, JC Armario‐Hita, L Martinez‐Pilar, ... Dermatologic therapy 32 (4), e12931, 2019 | 34 | 2019 |
Mar Llamas VelascoDermatologist at Hospital Universitario de La Princesa, Madrid在 salud.madrid.org 的电子邮件经过验证
